Absorption |
Blood-Brain Barrier | BBB+ | 0.9844 |
Human Intestinal Absorption | HIA+ | 0.9852 |
Caco-2 Permeability | Caco2+ | 0.8203 |
P-glycoprotein Substrate | Substrate | 0.8092 |
P-glycoprotein Inhibitor | Inhibitor | 0.8563 |
Inhibitor | 0.8570 |
Renal Organic Cation Transporter | Inhibitor | 0.7087 |
Distribution |
Subcellular localization | Mitochondria | 0.4659 |
Metabolism |
CYP450 2C9 Substrate | Non-substrate | 0.7438 |
CYP450 2D6 Substrate | Substrate | 0.8618 |
CYP450 3A4 Substrate | Substrate | 0.6468 |
CYP450 1A2 Inhibitor | Inhibitor | 0.9106 |
CYP450 2C9 Inhibitor | Non-inhibitor | 0.9319 |
CYP450 2D6 Inhibitor | Inhibitor | 0.9115 |
CYP450 2C19 Inhibitor | Non-inhibitor | 0.9025 |
CYP450 3A4 Inhibitor | Non-inhibitor | 0.9105 |
CYP Inhibitory Promiscuity | Low CYP Inhibitory Promiscuity | 0.7333 |
Excretion |
Toxicity |
Human Ether-a-go-go-Related Gene Inhibition | Weak inhibitor | 0.9537 |
Inhibitor | 0.7813 |
AMES Toxicity | Non AMES toxic | 0.8490 |
Carcinogens | Non-carcinogens | 0.9292 |
Fish Toxicity | High FHMT | 0.6477 |
Tetrahymena Pyriformis Toxicity | High TPT | 0.6541 |
Honey Bee Toxicity | Low HBT | 0.7401 |
Biodegradation | Not ready biodegradable | 0.9829 |
Acute Oral Toxicity | III | 0.7696 |
Carcinogenicity (Three-class) | Non-required | 0.7124 |